Browsing Harvard Medical School by Author "Buse, John B."
Now showing items 1-3 of 3
-
Cancer Incidence Among Those Initiating Insulin Therapy With Glargine Versus Human NPH Insulin
Stürmer, Til; Marquis, M. Alison; Zhou, Haibo; Meigs, James B.; Lim, Soo; Blonde, Lawrence; MacDonald, Eileen; Wang, Ray; LaVange, Lisa M.; Pate, Virginia; Buse, John B. (American Diabetes Association, 2013)OBJECTIVE To add to the evidence on comparative long-term effects of insulin analog glargine versus human NPH insulin on the risk for cancer. RESEARCH DESIGN AND METHODS We identified cohorts of initiators of glargine and ... -
Electronic Medical Record Cancer Incidence over Six Years Comparing New Users of Glargine with New Users of NPH Insulin
Lim, Soo; Stember, Katherine G.; He, Wei; Bianca, Porneala C.; Yelibi, Carine; Marquis, Alison; Stürmer, Til; Buse, John B.; Meigs, James B. (Public Library of Science, 2014)Background: Recent studies suggested that insulin glargine use could be associated with increased risk of cancer. We compared the incidence of cancer in new users of glargine versus new users of NPH in a longitudinal ... -
LEADER 3—Lipase and Amylase Activity in Subjects With Type 2 Diabetes: Baseline Data From Over 9000 Subjects in the LEADER Trial
Steinberg, William M.; Nauck, Michael A.; Zinman, Bernard; Daniels, Gilbert H.; Bergenstal, Richard M.; Mann, Johannes F.E.; Steen Ravn, Lasse; Moses, Alan C.; Stockner, Mette; Baeres, Florian M.M.; Marso, Steven P.; Buse, John B. (Lippincott Williams & Wilkins, 2014)Objectives: This report from the LEADER (Liraglutide Effect and Action in Diabetes: Evaluation of Cardiovascular Outcome Results) trial describes baseline lipase and amylase activity in type 2 diabetic subjects without ...